These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18395712)

  • 1. Depletion of serotonin decreases the effects of the kappa-opioid receptor agonist U-69593 on cocaine-stimulated activity.
    Zakharova E; Collins SL; Aberg M; Kumar A; Fernandez JB; Izenwasser S
    Eur J Pharmacol; 2008 May; 586(1-3):123-9. PubMed ID: 18395712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serotonin in the regulation of the dynorphinergic system by a kappa-opioid agonist and cocaine treatment in rat CNS.
    D'Addario C; Di Benedetto M; Izenwasser S; Candeletti S; Romualdi P
    Neuroscience; 2007 Jan; 144(1):157-64. PubMed ID: 17055175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity.
    Collins SL; Gerdes RM; D'Addario C; Izenwasser S
    Behav Pharmacol; 2001 Jul; 12(4):237-45. PubMed ID: 11548109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of kappa-opioid receptor agonists on long-term cocaine use and dopamine neurotransmission.
    Collins SL; D'Addario C; Izenwasser S
    Eur J Pharmacol; 2001 Aug; 426(1-2):25-34. PubMed ID: 11525767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist.
    Heidbreder CA; Schenk S; Partridge B; Shippenberg TS
    Synapse; 1998 Nov; 30(3):255-62. PubMed ID: 9776129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.
    Heidbreder CA; Goldberg SR; Shippenberg TS
    Brain Res; 1993 Jul; 616(1-2):335-8. PubMed ID: 8395306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists.
    Heidbreder CA; Babovic-Vuksanovic D; Shoaib M; Shippenberg TS
    J Pharmacol Exp Ther; 1995 Oct; 275(1):150-63. PubMed ID: 7562544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine.
    Thompson AC; Zapata A; Justice JB; Vaughan RA; Sharpe LG; Shippenberg TS
    J Neurosci; 2000 Dec; 20(24):9333-40. PubMed ID: 11125013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kappa-opioid receptor agonist U-69593 prevents cocaine-induced phosphorylation of DARPP-32 at Thr(34) in the rat brain.
    D'Addario C; Di Benedetto M; Candeletti S; Romualdi P
    Brain Res Bull; 2007 Jun; 73(1-3):34-9. PubMed ID: 17499634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
    Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
    Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
    Acri JB; Thompson AC; Shippenberg T
    Synapse; 2001 Mar; 39(4):343-50. PubMed ID: 11169785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine.
    Chefer VI; Morón JA; Hope B; Rea W; Shippenberg TS
    Neuroscience; 2000; 101(3):619-27. PubMed ID: 11113311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U-69593, a kappa opioid receptor agonist, decreases cocaine-induced behavioral sensitization in female rats.
    Puig-Ramos A; Santiago GS; Segarra AC
    Behav Neurosci; 2008 Feb; 122(1):151-60. PubMed ID: 18298258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats.
    Johnson-Davis KL; Hanson GR; Keefe KA
    Neurotox Res; 2003; 5(4):273-81. PubMed ID: 12835119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect dopamine agonists augment the locomotor activating effects of the kappa-opioid receptor agonist U-50,488 in preweanling rats.
    McDougall SA; Rodarte-Freeman AL; Nazarian A
    Dev Psychobiol; 1999 Apr; 34(3):183-93. PubMed ID: 10204094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
    Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):146-52. PubMed ID: 14712342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ibogaine on cocaine-induced efflux of [3H] dopamine and [3H] serotonin from mouse striatum.
    Sershen H; Hashim A; Lajtha A
    Pharmacol Biochem Behav; 1996 Apr; 53(4):863-9. PubMed ID: 8801590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593.
    Fuentealba JA; Gysling K; Andrés ME
    Synapse; 2007 Sep; 61(9):771-7. PubMed ID: 17568430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats.
    Chartoff EH; Potter D; Damez-Werno D; Cohen BM; Carlezon WA
    Neuropsychopharmacology; 2008 Oct; 33(11):2676-87. PubMed ID: 18185499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum.
    Steiner H; Gerfen CR
    J Comp Neurol; 1995 Mar; 353(2):200-12. PubMed ID: 7745131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.